STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis

Autor: Takashi Yao, Hitoshi Ojima, Ken Shirabe, Reina Yajima, Takahiro Takada, Takehiko Yokobori, Ryo Takahashi, Hiroyuki Kuwano, Ryuji Kato, Katsuya Osone, Hiroomi Ogawa, Junichi Nakamura, Chika Katayama, Takaaki Fujii, Yoko Motegi, Hironori Tatsuski
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Oncology Letters
ISSN: 1792-1082
1792-1074
Popis: Ulcerative colitis (UC) is thought to be associated with precancerous lesions that can ultimately lead to colon cancer. Therefore, diagnostic markers for colorectal dysplasia and cancer are urgently needed for patients with UC. Stathmin 1 (STMN1) is a novel cancer biomarker that is also a novel target for treatment in several cancers, including colon cancer. However, few studies have investigated the relationship between STMN1 expression and clinical features in colorectal dysplasia and cancer in patients with UC. The present study examined the clinical significance of STMN1 expression in colorectal dysplasia and cancer with UC. The present study performed an immunohistochemical analysis of 31 clinical colorectal samples from eight patients with colorectal dysplasia and/or cancer to assess the relationships between STMN1 expression and clinicopathological features including mismatch repair protein expression, rate of Ki-67 positivity, differentiation level, TNM stage, and UC duration. STNM1 expression was detected in 95.7% of dysplastic and cancerous lesions, whereas p53, the current diagnostic marker, was not expressed in 39.1% of dysplastic and cancerous lesions. Furthermore, STMN1 expression was associated with a high rate of positivity for Ki-67, a proliferation marker. Our data suggest that STMN1 in the colonic mucosa of UC patients may be useful as an early diagnostic marker of dysplasia and colitic cancer.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje